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S U M M A R Y
Background: The impact of obesity on the outcome of pneumonia is uncertain.
Methods: We retrospectively identiﬁed 266 hospitalized patients with proven pneumococcal or
Haemophilus community-acquired pneumoniawho had at least one bodymass index (BMI, kg/m2) value
documented in the 3 months before admission. Patients were classiﬁed as underweight (BMI <18.5),
normal weight (BMI 18.5 to <25), overweight (BMI 25 to <30), or obese (BMI 30). The association of
absolute BMI values and BMI categorieswith themortality at 30 days after admission for pneumoniawas
investigated.
Results: Increasing BMI values were associatedwith reduced 30-daymortality, even after adjustment for
signiﬁcant covariates (odds ratio 0.88, conﬁdence interval 0.81–0.96; p < 0.01). There was a signiﬁcant
trend towards lower mortality in the overweight and obese (non-parametric trend, p = 0.02).
Conclusions: Our data suggest that obesity may exert a protective effect against 30-day mortality from
community-acquired bacterial pneumonia.
 2010 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Obesity has reached pandemic proportions. Globally, it is
estimated that more than 1.1 billion people are overweight and
312 million of them obese.1 Community-acquired pneumonia is a
leading cause of morbidity and mortality worldwide, and bacterial
pathogens are the principal cause.2While it is widely assumed that
obesity adversely affects the course of acute infections, the impact
of this condition on the outcome of community-acquired bacterial
pneumonia (CABP) is still uncertain.3,4
Methods
Pneumonia
After approval by the Institutional Review Board, Baylor
College of Medicine, we reviewed complete electronic medical
records of patients admitted to the Michael E. DeBakey Veterans
Affairs Medical Center (Houston, TX, USA) between January 1,
2000 and August 30, 2007 for pneumococcal or Haemophilus* Corresponding author. Tel.: +1 613 761 4155; fax: +1 613 761 5260.
E-mail address: vcorrales@uottawa.ca (V.F. Corrales-Medina).
1201-9712/$36.00 – see front matter  2010 International Society for Infectious Disea
doi:10.1016/j.ijid.2010.09.011pneumonia diagnosed in accordance with the following criteria:
(1) clinical (lower respiratory symptoms) and radiological (new
pulmonary inﬁltrate) evidence of pneumonia within 48 h of
admission; and (2) 1 blood culture or pleural ﬂuid culture
yielding Streptococcus pneumoniae or Haemophilus inﬂuenzae; or
a sputum sample showing 10 inﬂammatory cells per epithelial
cell with predominance of Gram-positive cocci in pairs or Gram-
negative coccobacilli and a culture of that sputum yielding
pneumococci or H. inﬂuenzae, respectively, as the predominant
organism, with no other likely bacterial pathogens.
Obesity
Only patients with at least one body mass index (BMI; weight
in kg/(height in m)2) value documented within the 3 months
preceding the pneumonia and up to the time of admission were
included in the analyses. Using the most recent BMI, we
classiﬁed patients into underweight (BMI <18.5), normal weight
(BMI 18.5 to <25), overweight (BMI 25 to <30), or obese (BMI
30) as per the World Health Organization guidelines.5 In our
hospital system, the weights, heights, and BMIs of patients are
recorded at clinic visits depending upon efﬁciency of nursing
personnel, but without regard to the characteristics of individual
subjects.ses. Published by Elsevier Ltd. All rights reserved.
Table 1
Baseline patient characteristics by BMI categorya.
Underweight % (n=36) Normal weight % (n=107) Overweight % (n=70) Obese % (n=53) Total (n=266)
Age, mean (SD) 64 (12.5) 64.6 (12.5) 68.7 (12.2) 64 (10.1) 65.5 (12.1)
Age, median (IQR) 63 (54–72) 65 (54–76) 71.5 (58–79) 62 (58–74) 66 (28–92)
Whiteb 47 61 70 67 62
African Americanb 50 36 21 25 32
Hispanicb 3 3 9 8 6
Diabetesb 6 12 23 57 23
Coronary artery disease equivalentb,c 8 32 49 42 35
Congestive heart failureb 0 11 24 28 17
Chronic obstructive pulmonary disease 56 42 44 30 42
Chronic liver disease 3 5 9 0 5
Chronic kidney diseaseb 0 6 14 11 8
Cancer 11 6 7 4 6
HIV infection 19 16 10 4 12
Smokingb 78 61 47 45 56
Alcohol abuse 44 33 25 21 30
CURB-65, mean (SD) 1.3 (1.1) 1.5 (1.1) 1.6 (1.1) 1.3 (1.2) 1.5 (1.1)
BMI, body mass index; SD, standard deviation; IQR, interquartile range; HIV, human immunodeﬁciency virus.
a With the exception of mean age, median age, and CURB-65 score, data shown indicate percentage of patients with the characteristic within each BMI category.
b Unequal distribution among BMI categories (p<0.05 by Chi-square test or Fisher’s exact test).
c Includes coronary heart disease, cerebrovascular disease, and peripheral arterial disease.
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Mortality at 30 days post-admission was the primary outcome
evaluated. Demographic and clinical characteristics investigated
are listed in Table 1.
Statistics
Weperformed a descriptive analysis of demographic and clinical
variables. Univariate and multivariate analyses taking into account
absolute (continuous)BMI valueswereperformed to identify factors
related to 30-day mortality. The trend of mortality rates across BMI
categories was also evaluated with the non-parametric Cuzick
(nptrend) test. All calculations were conducted with Intercooled
Stata version 9.2 (StataCorp, College Station, TX, USA).
Results
Of 317 patients with bacterial pneumonia, 266 (84%) had a
documented BMI as described in the methods. Their baseline
characteristics are presented in Table 1. There were 36 (14%), 107
(40%), 70 (26%), and 53 (20%) patients in the underweight, normal
weight, overweight, and obese categories, respectively. Race
(p = 0.05), diabetes mellitus (p  0.01), coronary artery diseaseTable 2
Factors associated with mortality in pneumonia patients.
Univariate analysis OR (CI)
BMI 0.91 (0.84–0.98)
Age 1.04 (1.01–1.08)
Racea 0.47 (0.19–1.2)
Diabetes 0.79 (0.31–2.01)
Coronary artery disease equivalentb 1.63 (0.76–3.47)
Congestive heart failure 0.72 (0.24–2.18)
Chronic obstructive pulmonary disease 0.85 (0.4–1.83)
Chronic liver disease 2.69 (0.69–10.52)
Chronic kidney disease 1.22 (0.34–4.38)
Cancer 2.53 (0.77–8.31)
HIV infection 0.73 (0.21–2.56)
Smoking 1.08 (0.51–2.31)
Alcohol abuse 0.8 (0.34–1.89)
CURB-65 2.18 (1.53–3.12)
OR, odds ratio; CI, conﬁdence interval; BMI, body mass index; HIV, human immunode
a African American versus other races.
b Includes coronary heart disease, cerebrovascular disease, and peripheral arterial diequivalent (p  0.01), congestive heart failure (p = 0.01), chronic
kidney disease (p = 0.04), and cigarette smoking (p  0.01) had
signiﬁcantly different prevalence across BMI categories.
Thirty-one patients died within 30 days of admission (overall
mortality, 11.7%). Univariate analysis showed a negative associa-
tion between higher BMI and mortality at 30 days (odds ratio (OR)
0.91, conﬁdence interval (CI) 0.84–0.98, p = 0.01). Other variables
signiﬁcantly associated with 30-day mortality in the univariate
analysis are shown in Table 2. The negative association of BMIwith
mortality remained signiﬁcant in a multivariate logistic regression
model (OR 0.88, CI 0.81–0.96, p < 0.01) when adjusted for
signiﬁcant covariates (Table 2), speciﬁcally those with p  0.15
in the univariate analysis (age, race, active cancer, and CURB-65
score). Thismodel correctly classiﬁed 89% of the outcomes, had a p-
value of 0.7 in the Hosmer–Lemeshow Chi-square goodness-of-ﬁt
test, and showed an area under the receiver operating character-
istic (ROC) curve of 0.8. The signiﬁcance of this association and the
ﬁt of the model did not change after sequential inclusion of the
other variables investigated.
Mortality rates showed a statistically signiﬁcant trend towards
being higher in the underweight (19.4%) and normal weight (14%),
and lower in the overweight (8.6%) and obese (5.7%) groups
(nptrend p = 0.02) (Figure 1). There were no deaths among 17
patients with BMI 35.p-Value Multivariate analysis OR (CI) p-Value
0.01 0.88 (0.81–0.96) <0.01
0.01 1.00 (0.96–1.05) 0.06
0.1 0.43 (0.16–1.16) 0.09
0.62 - -
0.21 - -
0.56 - -
0.68 - -
0.16 - -
0.76 - -
0.13 2.51 (0.70–8.97) 0.16
0.63 - -
0.84 - -
0.61 - -
<0.01 2.23 (1.43–3.46) <0.01
ﬁciency virus.
sease.
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Figure 1. Thirty-daymortality rates by BMI category (non-parametric test for trend,
p = 0.02).
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Obesity has been associated with increased susceptibility to
acute infections, including those of the lower respiratory tract.6
Obesity affects the control of the respiratory cycle, increases
airway resistance and the work of breathing, impairs respiratory
muscle function and gas exchange, increases the risk of aspiration,
and increases the volume of distribution for certain antibiotic
drugs. Also, obesity-associated derangements in the homeostasis
of leptin and adiponectin (adipokines) have been linked to
impaired innate and adaptive immune responses to infectious
challenges.3 Counterintuitively, we found that obesity was
signiﬁcantly associated with decreased 30-day mortality in
patients with CABP.
Subnormal BMI almost always indicates malnutrition and
commonly reﬂects a debilitating status.7 Thus, it is not surprising
that previous studies have reported increasedmortality associated
with community-acquired pneumonia in patients with low
BMIs.8,9 Our study, however, not only found higher mortality
rates at lower BMI values, but also a linear and inverse relationship
between mortality rates and the different BMI categories,
suggesting that in fact obesity protects against death from at
least the bacterial forms of this infection. While counterintuitive,
our results are supported by the observations of other investiga-
tors. LaCroix et al.10 found a negative relationship between BMI
and pneumonia mortality and an inverse trend between mortality
and BMI quartiles (p < 0.01) in an observational study of 2600
middle-aged men. More recently, Inoue et al.11 showed a
protective effect of large BMIs (25) against pneumonia mortality
(OR 0.7, CI 0.5–0.8) and a signiﬁcant inverse trend between higher
BMI categories and death from the infection (p < 0.001) in a cohort
of 110 000 Japanese adults. However, these large studies relied on
medical codes for their case deﬁnitions, and their ability to
discriminate other processes that can mimic pneumonia (heart
failure, chronic lung disease, cancer, etc.) was not fully established.
Our study, although smaller, applied stringent criteria for the
deﬁnition of pneumonia and its bacterial etiology, improving the
validity of our ﬁndings. Altogether, these observations are
reminiscent of the ‘obesity paradox’ described for some non-
infectious conditions.12,13
Alternate explanations for our ﬁndings include the possibility
that overweight and obese persons may have fewer or less
advanced co-morbidities (e.g., chronic obstructive pulmonary
disease) than those with lower weight.14 Indeed, we found
signiﬁcant differences in the prevalence of major co-morbidities
across the different BMI categories (Table 1), but our sample size
prevented us from pursuing a stratiﬁed analysis by these factors,
and larger or more focused studies will have to address this issue.
Another way to examine this possibility would be by exploring thedirect causes of death in our patients and see if they relate more to
the pneumonia or the aforementioned co-morbidities. However,
attributing death to a co-morbid condition is difﬁcult, and 30-day
mortality is a standard and validated reporting technique in
pneumonia patients. Thirty-day mortality is believed to reﬂect the
maximal impact of the pneumonia on the mortality during this
period of time, whether the direct cause of death is the lung
infection, complications of it (metastatic or hospital-acquired
infections), or the acute worsening of pre-existing co-morbidities
(e.g., congestive heart failure).15 Some studies have suggested that
the high prevalence of pronounced disability, co-morbidities, and
symptoms in obese individuals motivates physicians to intervene
in these patients at earlier stages of conditions such as coronary
artery disease.16 A similar behavior in cases of obese patients with
pneumonia offers yet another explanation for our results and
cannot be ruled out. Finally, although we believe that the
measurement of BMIs in our hospital system is a non-discrimina-
tory process, our exclusion of subjects in whom no BMI was
recorded might possibly have introduced some selection bias.
Nevertheless, our results together with those of previous
studies suggest that obesity may have a paradoxical protective
effect against 30-daymortality from bacterial pneumonia acquired
in the community. Without questioning the detrimental effects of
obesity in the chronic health of people, the prospect of unrecog-
nized obesity-associated factors that protect against the progres-
sion of CABP deserves further consideration and study.
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